Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 38 member 6 (SLC38A6), also known as SNAT6 or NAT-1, is a probable sodium-coupled neutral amino acid transporter belonging to the SLC38 family. It is a transmembrane protein primarily found in the synaptic membranes of excitatory neurons in the brain and is not expressed in astrocytes[1][5]. The transporter is thought to be involved in the glutamate-glutamine cycle, supporting neurotransmitter balance and preventing excitotoxicity[1][2][5]. While closely related to other SLC38 family transporters, the exact substrate profile of SLC38A6 remains to be fully determined, though it exhibits a preference for L-glutamine and L-glutamate[2][4]. No direct disease associations or pharmacologically targeted drugs are currently documented for SLC38A6. Its role in maintaining neurotransmitter cycling highlights its potential relevance in neurobiology and disease, though functional and mechanistic data remain incomplete[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 38 member 6 (SLC38A6).